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ABSTRACT
As a critical tumor suppressor, p53 is inactivated in
human cancer cells by somatic gene mutation or dis-
ruption of pathways required for its activation. There-
fore, it is critical to elucidate the mechanism underlying
p53 activation after genotoxic and cellular stresses.
Accumulating evidence has indicated the importance of
posttranslational modiﬁcations such as acetylation in
regulating p53 stability and activity. However, the phys-
iological roles of the eight identiﬁed acetylation events
in regulating p53 responses remain to be fully under-
stood. By employing homologous recombination, we
introduced various combinations of missense mutations
(lysine to arginine) into eight acetylation sites of the
endogenous p53 gene in human embryonic stem cells
(hESCs). By determining the p53 responses to DNA
damage in the p53 knock-in mutant hESCs and their
derivatives, we demonstrate physiological importance
of the acetylation events within the core domain (K120
and K164) and at the C-terminus (K370/372/373/381/382/
386) in regulating human p53 responses to DNA
damage.
KEYWORDS human embryonic stem cells (hESCs),
p53, acetylation, homologous recombination,
DNA damage, cancer
INTRODUCTION
Tumor suppressor p53 is a transcription factor that directly
activates the transcription of hundreds of genes, including
p21, Mdm-2, noxa, and puma that are mediating p53-
dependent functions (Vousden and Prives, 2009). In addi-
tion, p53 also directly suppresses the expression of a num-
ber of genes, such as Nanog (Lin et al., 2005). While p53
remains in an unstable and inactive state in normal cells in
the absence of exogenous stresses, its protein level and
transcription activity are signiﬁcantly induced in response to
DNA damage and other cellular stresses (Vousden and
Prives, 2009). The interaction between p53 and E3 ligases
such as MDM2, all transcription targets of p53, leads to the
ubiquitination and rapid degradation of p53. In addition, the
interaction between p53 and Mdm2 or MdmX suppresses
the transcriptional activities of p53. These negative regula-
tory pathways are critical to prevent the hyperactivation of
p53 that can have devastating effects on organismal survival
and aging (Campisi, 2005; Liu et al., 2010).
p53 is critical to suppress cancer development in
humans, and the loss of wild-type p53 activity through direct
somatic gene mutation or disruption of pathways important
for p53 activation is required for cancer progression
(Vousden and Prives, 2009). Therefore, it is critical to elu-
cidate the pathways that activate p53. Accumulating evi-
dence indicates that posttranslational modiﬁcations of p53,
including phosphorylation and acetylation, are involved in
regulating p53 stability and activity. While phosphorylation
of p53 at N-terminus is important to activate some of p53-
dependent functions, none of the phosphorylation events
are critical for p53 activation (Chao et al., 2003; Chao et al.,
2006). Recent studies indicate that human p53 can be
acetylated at multiple lysine residues by Tip60 and CBP,
including K120, K164, K320, and the C-terminal K370/372/
373/381/382/386 (Brooks and Gu, 2011). Using human
cancer cell lines expressing p53 with various lysine to
arginine mutations, these studies indicate that K120R,
K164R as well as K120/164R double mutations partially
impaired the p53-dependent functions (Sykes et al., 2006;Sun-Ku Chung and Shengyun Zhu contributed equally to this work.
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Tang et al., 2006; Tang et al., 2008). In addition, mutation of
the eight acetylation sites to arginine abolishes the p53-
dependent functions, suggesting that these acetylation
events play synergistic and critical roles in activating p53
(Sykes et al., 2006; Tang et al., 2006, 2008).
The roles of acetylation have also been examined by
knock-in studies in mouse and ESCs. Employing p53 K3R
knock-in mouse, Li and colleagues demonstrate that acety-
lation of mouse p53 at K117/161/162 (corresponding to
human K120/164) is required for activating p53-dependent
transcription but dispensable for p53 stabilization (Li et al.,
2012). By generating p53 K120/164R knock-in hESCs, we
demonstrate that these two acetylation events are required
for p53-dependent transcription and stabilization (Zhang
et al., 2014). These ﬁndings demonstrate that acetylation
might have distinct impact on p53 stability and activity in
mouse and human cells.
RESULTS
Generation of K6R and K8R knock-in hESCs
To determine the functional interaction of the acetylation
events within the core domain and the C-terminus of p53, we
employed the same genetic approach to reveal the physio-
logical importance of eight acetylation events in regulating
human p53. The strategy to introduce the K to R mutations
(K370/372/373/381/382/386R, K6R; K120/164/370/372/373/
381/382/386R, K8R) into the endogenous p53 gene of
hESCs is the same as we described for the K120/164R
(K2R) knock-in mutation (Zhang et al., 2014) and is descri-
bed in Fig. 1. We introduced K8R mutations into two inde-
pendent hESC lines (HUES8 and HUES9) and K6R
mutations into the HUES8 hESCs. These knock-in hESCs
have normal karyotypes and can form well-differentiated
teratomas in immunodeﬁcient mice, conﬁrming their pluri-
potency (Fig. 2A and 2B). The full length cDNA of the p53
gene in the knock-in hESCs was sequenced to conﬁrm that
only the K to R mutations but no other mutations were
introduced into the p53 knock-in allele.
p53 stabilization is abolished in K8R hESCs
and ﬁbroblasts after DNA damage
Our previous studies have shown that K120/164R (K2R)
mutation is important for p53 stabilization and activation in
hESCs after DNA damage (Zhang et al., 2014). Cell lines
studies indicate that the acetylation at K120/164 works
synergistically with acetylation at the C-terminus (Tang
et al., 2008). To determine the physiological roles of the
acetylation of p53, we examined the impact of K8R muta-
tions on the p53 stability and activity in hESCs after DNA
damage. Consistent data were obtained from both K8R
knock-in hESC lines (HUES8 and HUES9), and the repre-
sentative data are presented.
To determine the impact of K8R on p53 stability, the
protein levels of p53 in p53+/−, K8R and p53−/− hESCs at
different time points after DNA damage. While the protein
levels of p53 were signiﬁcantly increased in p53+/− hESCs
after DNA damage, they remained unchanged in K8R
hESCs after DNA damage, indicating that DNA damage
induced stabilization of p53 is abolished in K8R hESCs
(Fig. 3A). Consistent with the ﬁndings that p53 is constitu-
tively acetylated (Tang et al., 2008), the basal levels of p53
protein were signiﬁcantly lower in K8R hESCs than in p53+/−
hESCs, indicating that acetylation stabilizes p53 in the
absence of exogenous stresses.
To conﬁrm that the role of this acetylation in stabilizing p53 is
not cell-type speciﬁc,wederived the ﬁbroblasts fromp53+/−and
K8R hESCs, and determined the p53 protein levels in these
cells after DNA damage. Our data conﬁrmed that the basal
levels of p53 protein were much lower in K8R ﬁbroblasts than
those in p53+/− ﬁbroblasts and could not be induced by DNA
damage (Fig. 3B). Therefore, we concluded that acetylation is
required to stabilize p53. In further support of this conclusion,
p53 was hyper-ubiquitinated in K8R hESCs and ﬁbroblasts
when compared with that in p53+/− cells (Fig. 3C). Consistent
with the increased ubiquitination of p53 in K8R cells, the inter-
action between Mdm2 and p53 was signiﬁcantly increased in
K8R hESCs than in p53+/− hESCs when analyzed by co-
immunoprecipitation (Fig. 3D). In addition, treatment with Nut-
lin-3, which speciﬁcally disrupts the interaction between Mdm2
and p53, signiﬁcantly increases the protein levels of p53 inK8R
hESCs, supporting the notion that the decreased protein levels
of p53 in K8R hESCs are primarily due to the increased p53-
Mdm2 interaction (Fig. 3E). In summary, these ﬁndings support
the notion that acetylation is required for p53 stabilization by
promoting p53-Mdm2 interaction.
p53-dependent functions are abolished in K8R hESCs
and ﬁbroblasts
Previous ﬁndings have shown that hESCs undergo p53-
dependent apoptosis and cell cycle G2/M checkpoint after
DNA damage (Song et al., 2010). Therefore, these p53-
dependent functions were analyzed in K8R hESCs after DNA
damage. p53-dependent apoptosis was abolished in the K8R
hESCsafterDNAdamage inducedbydoxorubicin (Fig. 4A). In
addition, p53-dependent G2/M checkpoint was essentially
compromised inK8RhESCsafter IR (Fig. 4B). Consistent with
these ﬁndings, p53-dependent transcription of target genes,
including p21, Mdm2, and Puma, was abolished in K8R
hESCs after IR (Fig. 4C). To conﬁrm that the impact of K8R
mutation on p53 transcription activity is not cell type depen-
dent, we analyzed the p53-dependent induction of p21 in the
ﬁbroblasts derived from K8R hESCs, indicating that p53-
dependent p21 expression is abolished in K8R ﬁbroblasts
both before and after DNA damage (Fig. 4D). Therefore, we
concluded that p53-dependent functions are abolished in K8R
hESCs after DNA damage.
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Figure 1. Generation of p53 acetylation site knock-in hESCs. (A) Genome conﬁguration of the p53 knockout allele in parental
p53+/− hESCs. (B) Germline conﬁguration of p53 WTallele in p53+/− hESCs. (C) The BAC-based knock-in vector to introduce K to R
mutations into the endogenous p53 gene in hESCs. The eight K to R mutations are indicated by asterisks. (D) Homologous
recombination between the WT p53 allele of p53+/− hESCs and the targeting vector led to knock-in hESCs with the selection cassette
inserted in the targeted allele. The PCR primers to screen for the FLP/FRT-mediated deletion are indicated. (E) Knock-in hESCs.
Transient expression of FLP in the targeted hESCs led to the excision of the selection marker from the knock-in allele. The sizes of
the NheI restriction fragments are indicated. (F) PCR (top panel) and Southern blotting (bottom panel) analyses of the knock-in
hESCs. Deletion of the selection cassette led to the loss of PCR ampliﬁcation by primers P1/P2 and the gain of PCR ampliﬁcation by
primers P1/P3. Genomic DNA was digested by Nhe1 for Southern blotting.
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Functional dissection of acetylation within the core
domain and C-terminus
To dissect the contribution of the acetylation events within
the core domain and C-terminus to activate p53 responses,
we examined the p53 responses to DNA damage in K6R
knock-in hESCs and compared to those in K2R (K120/164R)
hESCs. In contrast to the ﬁndings that p53 protein levels in
K8R hESCs were much lower than those in p53+/− hESCs
and could not be increased by DNA damage, the p53 protein
levels in K6R hESCs were induced by DNA damage
(Fig. 5A). While the half-life of p53 in K2R hESCs is signiﬁ-
cantly reduced when compared to that in p53+/− hESCs
(Zhang et al., 2014), the half-life of p53 in p53+/− hESCs is
similar to that in K6R hESCs (Fig. 5B). In contrast to that of
K8R, the interaction between p53 and Mdm2 is only mod-
estly increased in K6R hESCs, indicating that acetylation
within the core domain plays a key role in disrupting the
interaction between p53 and Mdm2 (Fig. 5C). However, the
ubiquitination levels were modestly reduced in K6R hESCs,
supporting the notion that the C-terminal lysine residues are
targeted for ubiquitination (Fig. 5D).
The p53-dependent functions in K6R hESCs
and ﬁbroblasts
In contrast to that in K8R and K2R hESCs that are abolished
in p53-dependent gene expression after DNA damage
(Fig. 6A), p53-dependent gene expression was higher in
K6R hESCs than those in p53+/− control hESCs both before
and after DNA damage, indicating that K6R mutation
increases the p53 responses to DNA damage in hESCs
(Fig. 6A). In further support of this conclusion, p53-depen-
dent apoptosis was abolished in K2R hESCs but increased
in K6R hESCs after IR (Fig. 6B). Therefore, in contrast to the
cell line data suggesting that K2R and K6R mutations syn-
ergistically disrupt p53-dependent transcription but not p53
stability (Li et al., 2012), our ﬁndings indicate that K2R and
K6R mutations have opposite impacts on p53 stability and
activity.
DISCUSSION
By generating acetylation site mutant knock-in hESCs, we
revealed the physiological roles of acetylation events within
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Figure 2. Characterization of p53 K6R and K8R knock-in hESCs. (A) Metaphase cells of the knock-in hESCs were examined and
exhibited normal karyotypes. Representative images are shown. (B) Knock-in hESCs formed well-differentiated teratomas in SCID
mice. Cells of each of the three germ layers were identiﬁed in the teratomas.
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the core domain and C-terminus and their functional inter-
action in activating human p53. There are several distinc-
tions between our conclusion and those reached in previous
cell line and mouse studies (Tang et al., 2008; Li et al.,
2012). First, while previous ﬁndings indicate that acetylation
is required for p53-dependent activity but dispensable for
p53 stabilization, our ﬁndings indicate that acetylation is
required for p53 stabilization. Second, previous ﬁndings
suggest that the acetylation at the core domain plays syn-
ergistic roles with the acetylation at the C-terminus in acti-
vating p53-dependent transcription. However, our ﬁndings
indicate that the mutations of the acetylation sites within the
core domain and at the C-terminus have opposite impact on
p53 stability and activity. These discrepancies could be due
to the intrinsic difference in the sequence of the mouse and
human p53 gene. In addition, the overexpression of various
p53 mutants in human cancer cell lines could also mask the
important roles of acetylation in p53 stabilization.
Our ﬁndings indicate that acetylation within the core
domain but not at the C-terminus plays a key role in the
disruption of the interaction between p53 and its E3 ligase
Mdm2. In this context, in addition to the N-terminus of p53,
Mdm2 binds to other regions of p53, including the core
domain (Vousden and Prives, 2009). Despite the ﬁnding that
p53-Mdm2 interaction is modestly increased in K6R cells,
p53 is more stable in K6R cells with reduced ubiquitination
when compared to wild type p53, indicating that the C-ter-
minal lysine residues are the preferential targets for ubiqui-
tination. In addition, the increased stability of p53 in K6R
cells after DNA damage leads to higher p53-dependent
transcription and apoptosis after DNA damage. Together
with previous ﬁndings, our data demonstrate the critical and
complex roles of acetylation in activating human p53
response to DNA damage and could provide the foundation
to develop novel strategies to activate p53 in human cancer
cells harboring WT but dysfunctional p53.
MATERIALS AND METHODS
Generation of acetyl defective p53 mutants
RP11-199F11, BAC clone including human p53, was purchased
from Invitrogen. The BAC based targeting vector was generated
and modiﬁed by recombineering in the E. coli strain SW102. To
obtain p53+/− hESCs, Neomycin marker was ﬁrstly used for
selection (Song et al., 2010). Each of wild type, or mutant p53 BAC
vector commonly had selection cassette (CAG-Neo-IRES-Puro-
polyA) through insertion into intron 4 of p53. By targeting each
BAC DNA into another allele of p53+/− hESCs through homologous
recombination, each clone harboring wild type, or acetyl mutant of
p53 was obtained from p53+/− hESCs. After transfecting FLP gene
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Figure 3. p53 stabilization is compromised in K8R hESCs and ﬁbroblasts. The protein levels of p53 in p53+/−, K8R and p53−/−
hESCs (A) and ﬁbroblasts (B) at different time points after DNA damage induced by doxorubicin. The genotypes and the hours of
doxorubicin treatment are indicated. The basal levels of p53 in K8R cells are lower than those of p53+/− cells. (C) The ubiquitination of
p53 in p53+/− and K8R hESCs and ﬁbroblasts. p53−/− hESCs and ﬁbroblasts were used as negative controls for speciﬁcity of
immunoprecipitation. (D) The interaction between p53 and Mdm2 in p53+/− and K8R cells by co-immunoprecipitation. p53 was
immunoprecipitated from p53+/− and K8R cells, and the levels of p53 and Mdm2 in the immunoprecipitate were determined by
Western blotting. (E) The stabilization of p53 in p53+/− and K8R hESCs by treating with Nutlin-3 for 24 h. The concentrations of Nutlin-
3 used are indicated on the top.
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Figure 4. p53-dependent functions are abolished in K8R hESCs and functions. (A) p53-dependent apoptosis in p53+/−, K8R and
p53−/− hESCs after 5 Gy of IR. The apoptotic cells were identiﬁed by staining with Annexin V. (B) The p53-dependent G2/M
checkpoint in p53+/−, K8R and p53−/− hESCs 1 h after 5 Gy of IR. Mean values from three independent experiments are shown with
SD. The P value between K8R cells and p53+/− cells is 0.02 (*), while the P value between p53−/− cells and p53+/− cells is 0.001 (**) as
shown is Fig. 4B. (C) p53-dependent gene expression in p53+/−, K8R and p53−/− hESCs after doxorubicin treatment. The mRNA
levels of p53 target genes were determined by quantitative real time PCR and standardized by the mRNA levels of GAPDH. (D) p53-
dependent induction of p21 is abolished in the ﬁbroblasts derived from K8R hESCs after doxorubicin treatment. The time points after



























Wt  K6R KO
Mdm2/p53    1    1.7 
C    3     6 (h)
Figure 5. The stability of p53 protein in K6R knock-in hESCs. (A) The protein levels of p53 in p53+/− and K6R hESCs after
doxorubicin treatment. The p53 and actin are indicated. (B) The protein levels of p53 in p53+/− and K6R hESCs at different time points
after treatment with cycloheximide (CHX) that inhibits protein synthesis. (C) The interaction between p53 and Mdm2 in p53+/− and
K6R hESCs was analyzed by co-immunoprecipitation. p53−/− hESCs were used as a negative control. (D) The ubiquitination of p53 in
p53+/−, K2R and K6R hESCs. The p53 protein was immunoprecipitated and the amount of ubiquitination was analyzed by anti-
ubiquitin antibody. p53−/− hESCs were used as a negative control.
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Cell culture for hESCs
In the presence of feeder layer, the HUES cells were cultured on
feeder layer in knockout DMEM supplemented with 10% knockout
serum replacement (KSR), 10% plasmanate, 1% PenStrep, 1%
Glutamine, 1% nonessential amino acids, 10 ng/mL bFGF, and
55 μmol/L β-mercaptoethanol as described (Cowan et al., 2004). In
the absence of feeder layer, HUES cells were cultured on matrigel-
coated plates in the mTeSR1 medium with 5× supplement. All tissue
culture reagents were purchased from Invitrogen.
Western blotting and immunoprecipitation analysis
Protein extracts fromhESCsor ﬁbroblasts derived from teratomawere
loaded on 6%–10% SDS-PAGE gel and transferred to nitrocellulose
membrane,whichwasprobedwithamonoclonal antibodyagainst p53
(pAb1801; Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal
antibody against Mdm2 (Ab-2; Oncogene Research), polyclonal
antibody against p21 or β-actin (Santa Cruz Biotechnology). The
membrane was subsequently probed with a horseradish peroxidase-
conjugated secondary antibody and developed with ECL PLUS
(Amersham, Piscataway, NJ). For co-immunoprecipitation analysis,
1–2 mg of whole cell protein extracts was immunoprecipitated with
anti-p53 antibody (FL393; Santa Cruz Biotechnology). The amount of
p53 and Mdm2 in the immunoprecipitate was analyzed by Western
blottingusingmonoclonal antibodyagainst p53 (pAb1801;SantaCruz
Biotechnology, Santa Cruz, CA), monoclonal antibody against Mdm2
(SMP-14; Santa Cruz Biotechnology, Santa Cruz, CA).
Quantitative real-time PCR
Real-time PCR was performed as previously described (Song et al.,
2010). The sequence of the primers was as follows: p21, 5′-ACC
TGGAGACTCTCAGGGTCG-3′ for forward primer, 5′-TTAGGGCT
TCCTCTTGGAGAAGAT-3′ for reverse primer; Mdm2, 5′-ATCGGA
CTCAGGTACATCTGTGAG-3′ for forward primer, 5′-AGGTTTCTC
A
B
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Figure 6. p53-dependent functions are abolished in K2R cells but increased in K6R cells. (A) p53-dependent gene expression
in p53+/−, K2R and K6R hESCs after doxorubicin treatment (0.2 μmol/L). The mRNA levels of each p53 target genes were determined
by quantitative PCR and standardized with the mRNA levels of GAPDH. (B) p53-dependent apoptosis in p53+/−, K2R and K6R
hESCs after doxorubicin treatment. The apoptotic cells were identiﬁed by staining with Annexin V. Mean value from three independent
experiments are shown with SD. n = 3.
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TTCCTGAAGCTCTTG-3′ for reverse primer; Puma, 5′-GACGACCT
CAACGCACAG-3′ for forward primer, 5′-CTAATTGGGCTCCATC
TCG-3′ for reverse primer; Noxa, 5′-TCCAGTTGGAGGCTGAGG
TT-3′ for forward primer, 5′-CACTCGACTTCCAGCTCTGC-3′ for
reverse primer; Killer5, 5′-CTCCTGCAAATATGGACAGGACTA-3′
for forward primer, 5′-TTAGCTCCACTTCACCTGAATCAC-3′ for
reverse primer.
Apoptosis assays
hESCs were cultured onto matrigel-coated plates in mTeSR1 med-
ium with 5× supplement (Invitrogen). hESCs were treated with
doxorubicin (0.2 μmol/L), or irradiated with γ-irradiation (5 Gy), and
harvested 8 and 16 h after treatment. Apoptotic cells were identiﬁed
by staining with Annexin V as previously described (Chao et al.,
2003).
In vivo ubiquitylation assays
For in vivo ubiquitylation assays, prior to cell collection, cells were
treated with Alln (25 μmol/L), or MG132 (25 μmol/L) for 4 h, and then
cells were lysed in modiﬁed RIPA buffer (1% Nonidet P-40, 0.1%
sodium dodecyl sulfate [SDS], Tris-HCl [pH 7.8], 150 mmol/L NaCl,
1 mmol/L dithiothreitol, 0.5 mmol/L EDTA, 25 μmol/L Alln, 25 μmol/L
MG132, 5 mmol/L N-ethylmaleimide, and fresh proteinase inhibitors)
with mild sonication. Cell lysates were immunoprecipitated with anti-
p53 antibody (FL393 AC; Santa Cruz Biotechnology, Santa Cruz,
CA) and analysed by Western blotting using anti-ubiquitin antibody
(P4D1; Santa Cruz Biotechnology, Santa Cruz, CA) or anti-p53
antibody (pAb1801; Santa Cruz Biotechnology) (Feng et al., 2005).
Analysis of p53 stability
For in vivo p53 degradation assays, hESCs were incubated with
cycloheximide (100 μg/mL). Cells were harvested at 20, 40, and
80 min later, subjected to Western blotting using anti-p53 antibody
(pAb1801; Santa Cruz Biotechnology, Santa Cruz, CA). The inten-
sity of bands was measured by densitometry.
Karyotyping analysis
Karyotyping of the mutant hESC clones was carried out by Cell Line
Genetics (Madison, WI).
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